Duke medical team creates, implants bioengineered vein

06/9/2013 | American City Business Journals · Nature World News

Duke University physicians have successfully fashioned a bioengineered vein and implanted it into the arm of a patient with end-stage renal disease in the nation's first clinical trial of its kind. The vessel was grown from donated human blood cells on a scaffold and carries no risk of rejection. "We hope this sets the groundwork for how these things can be grown, how they can incorporate into the host and how they can avoid being rejected immunologically," said Dr. Jeffrey H. Lawson. "A blood vessel is really an organ -- it's complex tissue. We start with this, and one day we may be able to engineer a liver or a kidney or an eye."

View Full Article in:

American City Business Journals · Nature World News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA